P&G Reports Q2 Earnings Decline Amidst Major Restructuring and Glad JV Divestiture
Summary
Procter & Gamble reported a 7% decline in Q2 net earnings and diluted EPS, with flat organic sales, while continuing its significant $1.5-$2.0 billion restructuring plan and announcing the divestiture of its minority interest in the Glad joint venture.
Key Events
-
Q2 Financial Performance Declines
Net sales increased 1% to $22.2 billion, but operating income and net earnings both decreased by 7% compared to the prior year. Diluted EPS fell 5% to $1.78, with organic sales remaining flat.
-
Significant Restructuring Plan Underway
The company incurred $369 million in Q2 restructuring charges as part of a $1.5-$2.0 billion plan to reduce up to 7,000 non-manufacturing personnel by fiscal 2027, aimed at improving cost structure and competitiveness.
-
Glad Joint Venture Divestiture Announced
P&G will sell its minority interest in the Glad joint venture to The Clorox Company, expecting approximately $500 million in cash proceeds and a $250-$300 million after-tax gain in Q3 FY2026.
-
Gillette Intangible Asset Value Exceeds Carrying Value
Annual impairment testing confirmed the Gillette indefinite-lived intangible asset's fair value exceeds its $12.8 billion carrying value by over 10%, though it remains sensitive to macroeconomic changes.
Analysis
Procter & Gamble's second-quarter results show a notable decline in profitability, with operating income and net earnings both down 7%. This is partly attributable to ongoing restructuring charges as the company executes a substantial multi-year plan to streamline its operations and workforce. While these restructuring efforts are designed to improve long-term cost structure and competitiveness, they are currently impacting GAAP earnings. The announced divestiture of the Glad joint venture is a positive step in portfolio optimization, expected to generate significant cash and a gain in the next quarter. Investors should monitor the progress of the restructuring plan and its impact on future profitability, as well as the successful completion of the Glad divestiture. The flat organic sales growth indicates a challenging market environment despite pricing increases.
At the time of this filing, PG was trading at $151.10 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $350.3B. The 52-week trading range was $137.62 to $179.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.